YC
Chalandon, Yves
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Incidence and Risk Factors for Infection in Heart Transplant Recipients on Posttransplant Extracorporeal Membrane Oxygenation (ECMO) | Transplantation direct | 2025 | 17 | 49 | |||
| Comparing variable and feature selection strategies for prediction - protocol of a simulation study in low-dimensional transplantation data | PloS one | 2025 | 18 | 148 | |||
| Reintegration Into the Workforce After Kidney Transplantation Based on Urbanization Status in Switzerland | Kidney international reports | 2025 | 107 | 190 | |||
| Blood virome after allogeneic hematopoietic stem cell transplantation | Open forum infectious diseases | 2025 | 65 | 117 | |||
| Toxicités hématologiques après CAR-T cells, recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC) | Bulletin du cancer | 2025 | 30 | 0 | |||
| Traitement de la maladie greffe contre-hôte aiguë : quelle troisième ligne après stéroïdes et ruxolitinib ? (SFGM-TC) | Bulletin du cancer | 2025 | 9 | 138 | |||
| Outcome of Patients Transplanted for C3 Glomerulopathy and Primary Immune Complex-Mediated Membranoproliferative Glomerulonephritis | Kidney international reports | 2025 | 51 | 321 | |||
| Isolation measures during the COVID-19 pandemic in transplant units may decrease respiratory infection rates and improve non-relapse mortality | Bone marrow transplantation | 2025 | 7 | 0 | |||
| Invasive Candida infections in solid organ transplant recipients between 2008 and 2020 | American Journal of Transplantation | 2025 | 24 | 92 | |||
| Surgical site infections, risk factors, and outcomes after liver transplant | JAMA network open | 2025 | 75 | 212 | |||
| Role of allo-HCT in "nonclassical" MPNs and MDS/MPNs : recommendations from the PH&G Committee and the CMWP of the EBMT | Blood | 2025 | 45 | 176 | |||
| Utility of the 2024 best practice recommendations from the EBMT Cellular Therapy and Immunobiology Working Party for use of donor lymphocyte infusions after allogeneic hematopoietic stem cell transplantation | Bone marrow transplantation | 2024 | 86 | 0 | |||
| Allogeneic hematopoietic cell transplantation for acute myeloid leukemia with hyperdiploid complex karyotype | Bone marrow transplantation | 2024 | 48 | 0 | |||
| Anti-BCMA and GPRC5D bispecific antibodies in relapsed/refractory primary plasma cell leukemia : a case report | Frontiers in immunology | 2024 | 42 | 127 | |||
| Nilotinib with or without cytarabine for Philadelphia-positive acute lymphoblastic leukemia | Blood | 2024 | 72 | 0 | |||
| Remission of relapsed/refractory classical Hodgkin lymphoma induced by brentuximab vedotin and pembrolizumab combination after allogeneic hematopoietic stem cell transplantation : a case report | Frontiers in immunology | 2024 | 61 | 140 | |||
| Hematopoietic cell transplantation for older acute myeloid leukemia patients in first complete remission : results of a randomized phase III study | Haematologica | 2024 | 77 | 86 | |||
| Sexual health-related psychological and emotional life after allogeneic haematopoietic stem-cell transplantation | The lancet. Haematology | 2024 | 60 | 0 | |||
| NGS-based stratification refines the risk stratification in T-ALL and identifies a Very High-Risk subgroup of patients | Blood | 2024 | 102 | 0 | |||
| Bone marrow graft versus peripheral blood graft in haploidentical hematopoietic stem cells transplantation : a retrospective analysis in1344 patients of SFGM-TC registry | Journal of hematology & oncology | 2024 | 66 | 49 | |||
| Severe anaphylaxis after chimeric antigen receptor T-cell injection : a case report | EJHaem | 2024 | 57 | 146 | |||
| Unrelated donor transplantation with posttransplant cyclophosphamide vs ATG for myelodysplastic neoplasms | Blood advances | 2024 | 70 | 309 | |||
| Outcomes of CMML patients undergoing allo-HCT are significantly worse compared to MDS-a study of the CMWP of the EBMT | American journal of hematology | 2024 | 149 | 77 | |||
| Significance of Measurable Residual Disease in Adult Philadelphia Chromosome-Positive ALL : A GRAAPH-2014 Study | Journal of clinical oncology | 2024 | 58 | 0 | |||
| Management of adult patients with CMML undergoing allo-HCT : recommendations from the EBMT PH&G Committee | Blood | 2024 | 105 | 580 | |||
| Central nervous system manifestations in acute and chronic graft-versus-host disease | Brain | 2024 | 99 | 123 | |||
| Long-term outcome after autologous BCR::ABL1-negative peripheral blood stem cell transplantation in adults with Philadelphia-positive acute lymphoblastic leukemia : a comparative study | Haematologica | 2024 | 39 | 38 | |||
| Mismatched related donor allogeneic haematopoietic cell transplantation compared to other donor types for Ph+ chronic myeloid leukaemia : A retrospective analysis from the Chronic Malignancies Working Party of the EBMT | British journal of haematology | 2024 | 53 | 0 | |||
| Infectious disease events in people with HIV receiving kidney transplantation : Analysis of the Swiss HIV Cohort Study and the Swiss Transplant Cohort Study | BMC infectious diseases | 2024 | 65 | 128 | |||
| Graft-versus-host disease prophylaxis with post-transplantation cyclophosphamide in chronic myeloid leukemia patients undergoing allogeneic hematopoietic cell transplantation from an unrelated or mismatched related donor : a comparative study from the chronic malignancies working party of the EBMT (CMWP-EBMT) | Transplantation and cellular therapy | 2024 | 88 | 89 | |||
| Hematopoietic cell transplantation and cellular therapies in Switzerland. Evolution over 25 years. A report from the stem cell transplantation and cellular therapies working groups of the SBST 1997-2021 | Hematological oncology | 2024 | 87 | 0 | |||
| Do infectious diseases after kidney retransplantation differ from those after first kidney transplantation ? | Open forum infectious diseases | 2024 | 115 | 115 | |||
| Pitfalls in Valganciclovir Prophylaxis Dose Adjustment Based on Renal Function in Kidney Transplant Recipients | Transplant international | 2024 | 113 | 137 | |||
| Incidence and outcome of central nervous system relapse after hematopoietic stem cell transplantation in patients suffering from acute myeloid leukemia and acute lymphoblastic leukemia : a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation | Haematologica | 2024 | 120 | 211 | |||
| Impact of intermittent versus continuous infusions on central line-associated bloodstream infection risk in haemato-oncology patients : a quasi-experimental study | The Journal of hospital infection | 2024 | 60 | 307 | |||
| Allogeneic haematopoietic cell transplantation for chronic myeloid leukaemia in Switzerland in the face of rapid development of effective drugs | Swiss medical weekly | 2024 | 63 | 22 | |||
| Protocol for a multicentric, double-blind, randomised controlled trial of hyperbaric oxygen therapy (HBOT) versus sham for treating vaso-occlusive crisis (VOC) in sickle cell disease (SCD) in patients aged 8 years or older (HBOT-SCD study) | BMJ open | 2024 | 107 | 221 | |||
| BK polyomavirus serotype-specific antibody responses in blood donors and kidney transplant recipients with and without new-onset BK polyomavirus-DNAemia : A Swiss Transplant Cohort Study | American journal of transplantation | 2024 | 50 | 104 | |||
| Identifying the drivers of overall rating of cancer care: Insights from the second wave of the Swiss Cancer Patient Experiences study | Cancer | 2024 | 165 | 157 | |||
| Pr Connie J. Eaves (1944–2024) | Bulletin du cancer | 2024 | 72 | 1 | |||
| Neoantigen-specific T-cell response after donor lymphocyte infusion associates with favorable outcome in a patient with i(12p) germ cell tumor, acute leukemia and sarcoma of the same clonal origin | Haematologica | 2024 | 106 | 88 | |||
| Antibody and T-cell response to bivalent booster SARS-CoV-2 vaccines in people with compromised immune function (COVERALL-3) | The Journal of infectious diseases | 2024 | 522 | 581 | |||
| Surgical site infections after kidney transplantation are independently associated with graft loss | American journal of transplantation | 2024 | 61 | 223 | |||
| Frequency and impact on renal transplant outcomes of urinary tract infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species | Frontiers in medicine | 2024 | 89 | 36 | |||
| Pre-engraftment bacteremia after allogeneic hematopoietic cell transplantation without primary fluoroquinolone antibacterial prophylaxis | Transplant infectious disease | 2024 | 65 | 158 | |||
| Graft-versus-host disease after anti-CD19 chimeric antigen receptor T-cell therapy following allogeneic hematopoietic cell transplantation : a transplant complications and paediatric diseases working parties joint EBMT study | Leukemia | 2024 | 89 | 0 | |||
| Epidemiology, outcomes and risk factors for recurrence of Clostridioides difficile infections following allogeneic hematopoietic cell transplantation : a longitudinal retrospective multicenter study | Bone marrow transplantation | 2024 | 84 | 87 | |||
| Technical comment on : Trottmann M, et al. Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data | Swiss medical weekly | 2024 | 46 | 63 | |||
| NK and T cell repertoire is established early after allogeneic HSCT and is profoundly imprinted by CMV reactivation | Blood advances | 2024 | 115 | 100 | |||
| Routine infectious disease consultation prior to an allogeneic hematopoietic cell transplant | Open forum infectious diseases | 2023 | 86 | 127 | |||
| Vaccine-preventable infections among solid organ transplant recipients in Switzerland | JAMA network open | 2023 | 139 | 170 | |||
| Revisiting cytomegalovirus serology in allogeneic hematopoietic cell transplant recipients | Clinical infectious diseases | 2023 | 104 | 181 | |||
| Donation type and the effect of pre-transplant donor specific antibodies - Data from the Swiss Transplant Cohort Study | Frontiers in immunology | 2023 | 160 | 52 | |||
| Bronchiolitis obliterans syndrome following SARS-CoV-2 infection in an allogeneic hematopoietic stem cell recipient | American journal of transplantation | 2023 | 309 | 276 | |||
| Bloodstream infections in allogeneic haematopoietic cell recipients from the swiss transplant cohort study: trends of causative pathogens and resistance rates | Bone marrow transplantation | 2023 | 153 | 103 | |||
| Real-world experience of sorafenib maintenance after allogeneic hematopoietic stem cell transplantation for FLT3-ITD AML reveals high rates of toxicity-related treatment interruption | Frontiers in oncology | 2023 | 73 | 143 | |||
| Allogeneic hematopoietic stem cell transplantation in non-Hodgkin lymphoma in Switzerland, 30 years of experience : Sooner is better | EJHaem | 2023 | 70 | 119 | |||
| CMV Infection After Letermovir Primary Prophylaxis Discontinuation in Allogeneic Hematopoietic Cell Transplant Recipients | Open forum infectious diseases | 2023 | 141 | 110 | |||
| Allogeneic hematopoietic stem cell transplantation for NK/T-cell lymphoma : an international collaborative analysis | Leukemia | 2023 | 63 | 78 | |||
| CMV serostatus and T-cell repertoire diversity 5 years after allogeneic hematopoietic stem cell transplantation | Leukemia & lymphoma | 2023 | 77 | 87 | |||
| Clinical prediction model for prognosis in kidney transplant recipients (KIDMO) : study protocol | Diagnostic and prognostic research | 2023 | 79 | 232 | |||
| Immune monitoring-guided vs fixed duration of antiviral prophylaxis against cytomegalovirus in solid-organ transplant recipients. A Multicenter, Randomized Clinical Trial | Clinical infectious diseases | 2023 | 150 | 275 | |||
| Outcomes after allogeneic hematopoietic cell transplant in patients diagnosed with blast phase of myeloproliferative neoplasms : A retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation | American journal of hematology | 2023 | 72 | 0 | |||
| Prognostic value and oncogenic landscape of TP53 alterations in adult and pediatric T-ALL | Blood | 2023 | 76 | 208 | |||
| Conduite à tenir devant une prédisposition génétique aux hémopathies malignes chez un patient candidat à l’allogreffe de cellules souches hématopoïétiques (CSH) : recommandations de la SFGM-TC | Bulletin du cancer | 2023 | 24 | 0 | |||
| Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes : a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMT | The lancet. Haematology | 2023 | 67 | 0 | |||
| Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with Busulfan | Bone marrow transplantation | 2023 | 13 | 66 | |||
| Genetic alterations and MRD refine risk assessment for KMT2A-rearranged B-cell precursor ALL in adults : a GRAALL study | Blood | 2023 | 82 | 89 | |||
| Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors : A retrospective study by the chronic malignancies working party of the EBMT | American journal of hematology | 2023 | 88 | 81 | |||
| Adult low hypodiploid acute lymphoblastic leukemia emerges from pre-leukemic TP53-mutant clonal hematopoiesis | Blood cancer discovery | 2023 | 341 | 212 | |||
| Longitudinal Detection of Twenty DNA and RNA Viruses in Allogeneic Hematopoietic Stem Cell Transplant Recipients Plasma | Viruses | 2023 | 157 | 158 | |||
| Antibody Response After the Third SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients and People Living With HIV (COVERALL-2) | Open forum infectious diseases | 2023 | 94 | 90 | |||
| Bacteremia During the First Year After Solid Organ Transplantation : An Epidemiological Update | Open forum infectious diseases | 2023 | 128 | 126 | |||
| Salvage Treatment of Refractory HSV Oral Lesions with Pritelivir in Allogeneic Hematopoietic Cell Transplant Recipients | Antimicrobial agents and chemotherapy | 2023 | 106 | 408 | |||
| Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine | Blood cancer journal | 2023 | 66 | 21 | |||
| Hepatitis E Virus Infection Epidemiology in Recipients of Allogeneic Hematopoietic Cell Transplant | Open forum infectious diseases | 2023 | 70 | 107 | |||
| Allogeneic hematopoietic stem cell transplantation in Hodgkin lymphoma in Switzerland, 20 years of experience : 2001-2020 | EJHaem | 2023 | 90 | 144 | |||
| Pharmacokinetic Modeling and Simulation with Pharmacogenetic Insights Support the Relevance of Therapeutic Drug Monitoring for Myeloablative Busulfan Dosing in Adult HSCT | Transplantation and cellular therapy | 2023 | 91 | 146 | |||
| Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2 : Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2) | Open forum infectious diseases | 2023 | 146 | 107 | |||
| Impact of central nervous system involvement in adult patients with Philadelphia-negative acute lymphoblastic leukemia : a GRAALL-2005 study | Haematologica | 2023 | 90 | 68 | |||
| SARS-CoV-2 m-RNA Vaccine Response in Immunocompromised Patients: A Monocentric Study Comparing Cancer, People Living with HIV, Hematopoietic Stem Cell Transplant Patients and Lung Transplant Recipients | Vaccines | 2023 | 94 | 132 | |||
| Outcome after allogeneic stem cell transplantation with haploidentical versus HLA-matched donors in patients with higher-risk MDS | Bone marrow transplantation | 2023 | 50 | 25 | |||
| The impact of pre-transplant donor specific antibodies on the outcome of kidney transplantation – Data from the Swiss transplant cohort study | Frontiers in immunology | 2022 | 195 | 108 | |||
| Invasive Mold Infections in Allogeneic Hematopoietic Cell Transplant Recipients in 2020: Have We Made Enough Progress? | Open forum infectious diseases | 2022 | 272 | 249 | |||
| Human pegivirus-1 replication influences NK cell reconstitution after allogeneic haematopoietic stem cell transplantation | Frontiers in immunology | 2022 | 120 | 104 | |||
| Atypical pulmonary phaeohyphomycosis due to Aureobasidium spp. - case report and brief literature review | Swiss medical weekly | 2022 | 185 | 91 | |||
| Analysis of T cell Repertoire and Transcriptome Identifies Mechanisms of Regulatory T cell (Treg) Suppression of GvHD | Blood | 2022 | 505 | 165 | |||
| Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time: an EBMT mega-file study | Haematologica | 2022 | 439 | 65 | |||
| Rhinovirus infections among hematopoietic stem cell transplant recipients: a pre-transplant dilemma? | Viruses | 2022 | 214 | 216 | |||
| Use of statins after liver transplantation is associated with improved survival: results of a nationwide study | Alimentary pharmacology & therapeutics | 2022 | 153 | 258 | |||
| Therapeutic Drug Monitoring of Orally Administered Letermovir Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant Recipients | Antimicrobial agents and chemotherapy | 2022 | 106 | 310 | |||
| Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome | Leukemia | 2022 | 71 | 9 | |||
| Frequency and causes of antifungal treatment changes in allogeneic haematopoïetic cell transplant recipients with invasive mould infections | Mycoses | 2022 | 306 | 207 | |||
| Kinetics of disappearance and appearance of isoagglutinins A and B after ABO-incompatible hematopoietic stem cell transplantation | Bone marrow transplantation | 2022 | 148 | 184 | |||
| Unrelated Cord Blood Transplantation in Children, Adolescents, and Young Adults with Acute Leukemia or Myelodysplastic Syndrome : A Retrospective Comparative Study from the French Society for Bone Marrow Transplantation and Cellular Therapy Between Real-World Data and Previously Reported Results of a Randomized Clinical Trial | Transplantation and cellular therapy | 2022 | 114 | 68 | |||
| Inhibiteurs des Janus kinases : nouvelles perspectives pour la médecine de précision ? | Revue médicale suisse | 2022 | 60 | 75 | |||
| Reduced intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid leukemia : a study from the ALWP of the EBMT | Bone marrow transplantation | 2022 | 97 | 0 | |||
| Allogeneic hematopoietic cell transplantation in patients with therapy-related myeloid neoplasm after breast cancer : a study of the Chronic Malignancies Working Party of the EBMT | Bone marrow transplantation | 2022 | 45 | 0 | |||
| GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantation | Journal of cancer research and clinical oncology | 2022 | 392 | 203 | |||
| Basic characteristics and safety of donation in related and unrelated haematopoietic progenitor cell donors - first 10 years of prospective donor follow-up of Swiss donors | Bone marrow transplantation | 2022 | 54 | 0 | |||
| Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMT | Bone marrow transplantation | 2022 | 271 | 125 | |||
| Developing and testing a Corona VaccinE tRiAL pLatform (COVERALL) to study Covid-19 vaccine response in immunocompromised patients | BMC infectious diseases | 2022 | 147 | 87 | |||
| Defibrotide Shows Efficacy in the Prevention of Sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation : A Retrospective Study | Transplantation and cellular therapy | 2022 | 139 | 216 | |||
| Epidemiology and outcomes of bone and joint infections in solid organ transplant recipients | American journal of transplantation | 2022 | 245 | 143 | |||
| T cell receptor sequencing reveals reduced clonal breadth of T-cell responses against SARS-CoV-2 after natural infection and vaccination in allogeneic hematopoietic stem cell transplant recipients | Annals of oncology | 2022 | 264 | 138 | |||
| Antibody Response in Immunocompromised Patients After the Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine BNT162b2 or mRNA-1273: A Randomized Controlled Trial | Clinical infectious diseases | 2022 | 151 | 88 | |||
| When and how do we stop antifungal treatment for an invasive mould infection in allogeneic haematopoietic cell transplant recipients? | Mycoses | 2022 | 103 | 96 | |||
| Analysis of biological models to predict clinical outcomes based on HLA-DPB1 disparities in unrelated transplantation | Blood advances | 2021 | 321 | 135 | |||
| The EBMT Cytogenetic Risk Score maintains its prognostic significance in acute myeloid leukemia following allogeneic stem cell transplantation in a cohort with 40% of patients transplanted with in vitro partial T-cell depleted graft | Bone marrow transplantation | 2021 | 352 | 0 | |||
| Infectious complications and graft outcome following treatment of acute antibody-mediated rejection after kidney transplantation: A nationwide cohort study | PLOS ONE | 2021 | 328 | 400 | |||
| Unmasking viral sequences by metagenomic next-generation sequencing in adult human blood samples during steroid-refractory/dependent graft-versus-host disease | Microbiome | 2021 | 408 | 381 | |||
| Inferior Outcome of Addition of the Aminopeptidase Inhibitor Tosedostat to Standard Intensive Treatment for Elderly Patients with AML and High Risk MDS | Cancers | 2021 | 238 | 195 | |||
| Outcomes following second allogeneic haematopoietic cell transplantation in patients with myelofibrosis: a retrospective study of the Chronic Malignancies Working Party of EBMT | Bone marrow transplantation | 2021 | 264 | 0 | |||
| Busulfan-cyclophosphamide versus cyclophosphamide-busulfan as conditioning regimen before allogeneic hematopoietic cell transplantation: a prospective randomized trial | Annals of hematology | 2021 | 324 | 198 | |||
| Development of an integrated model of care for allogeneic stem cell transplantation facilitated by eHealth-the SMILe study | Supportive care in cancer | 2021 | 283 | 159 | |||
| Thiotepa-busulfan-fludarabine (TBF) conditioning regimen in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis: an outcome analysis from the Chronic Malignancies Working Party of the EBMT | Bone marrow transplantation | 2021 | 283 | 0 | |||
| Letermovir Primary Prophylaxis in High-Risk Hematopoietic Cell Transplant Recipients: A Matched Cohort Study | Vaccines | 2021 | 207 | 304 | |||
| Comment faire face à un événement inattendu pouvant modifier l’activité normale de thérapie cellulaire ? Recommandations de la Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) | Bulletin du cancer | 2021 | 371 | 0 | |||
| Pre-transplant donor-specific HLA antibodies and risk for poor first-year renal transplant outcomes: results from the Swiss Transplant Cohort Study | Transplant international | 2021 | 251 | 484 | |||
| Antibody responses to SARS-CoV2 vaccination in allogeneic hematopoietic stem cell transplant recipients | Bone marrow transplantation | 2021 | 341 | 2 | |||
| Risk factors for a severe form of COVID-19 after allogeneic haematopoietic stem cell transplantation: a Société Francophone de Greffe de Moelle et de Thérapie cellulaire (SFGM-TC) multicentre cohort study | British journal of haematology | 2021 | 273 | 197 | |||
| Predictors of breakthrough clinically significant cytomegalovirus infection during letermovir prophylaxis in high-risk hematopoietic cell transplant recipients | Immunity, inflammation and disease | 2021 | 374 | 207 | |||
| Temporal trends, risk factors and outcomes of infections due to extended-spectrum β-lactamase producing Enterobacterales in Swiss solid organ transplant recipients between 2012 and 2018 | Antimicrobial resistance and infection control | 2021 | 386 | 157 | |||
| Clinical considerations of isavuconazole administration in high-risk hematological patients: a single-center 5-year experience | Mycopathologia | 2021 | 245 | 279 | |||
| Improved outcome in children compared to adolescents and young adults after allogeneic hematopoietic stem cell transplant for acute myeloid leukemia: a retrospective study from the Francophone Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC) | Journal of cancer research and clinical oncology | 2021 | 213 | 174 | |||
| Clinical considerations on posaconazole administration and therapeutic drug monitoring in allogeneic hematopoietic cell transplant recipients | Medical mycology | 2021 | 364 | 1 | |||
| Use of induction therapy in pediatric heart transplant recipients in Switzerland - Analysis of the Swiss national database | Transplant immunology | 2021 | 174 | 0 | |||
| Pre-transplant social adaptability index and clinical outcomes in renal transplantation: The Swiss Transplant Cohort study | Clinical transplantation | 2021 | 164 | 0 | |||
| Clinical and Pharmacological Considerations for Concomitant Administration of Posaconazole and Isavuconazole with Letermovir | Antimicrobial agents and chemotherapy | 2021 | 251 | 441 | |||
| Real-life considerations on antifungal treatment combinations for the management of invasive mold infections after allogeneic cell transplantation | Journal of Fungi | 2021 | 191 | 151 | |||
| Successful treatment of central nervous system lymphoproliferative disorder in a kidney-pancreas and stem cell transplanted patient using intrathecal rituximab | BMJ case reports | 2021 | 244 | 1 | |||
| Genetic T-cell receptor diversity at 1 year following allogeneic hematopoietic stem cell transplantation | Leukemia | 2020 | 406 | 313 | |||
| Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS | Leukemia | 2020 | 55 | 1 | |||
| Conditioning-based outcomes after allogeneic transplantation for myeloma following a prior autologous transplant (1991-2012) on behalf of EBMT CMWP | European Journal of Haematology | 2020 | 168 | 0 | |||
| Ibrutinib added to 10-day decitabine for older patients with AML and higher risk MDS | Blood Advances | 2020 | 291 | 122 | |||
| Genetic Susceptibility to Hepatic Sinusoidal Obstruction Syndrome in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation | Biology of Blood and Marrow Transplantation | 2020 | 346 | 0 | |||
| Thromboembolism prophylaxis in adult patients with acute lymphoblastic leukemia treated in the GRAALL-2005 study | Blood | 2020 | 184 | 395 | |||
| Torque Teno Virus as a potential biomarker for complications and survival after allogeneic hematopoietic stem cell transplantation | Frontiers in Immunology | 2020 | 563 | 213 | |||
| Adult T-cell acute lymphoblastic leukemias with IL7R pathway mutations are slow-responders who do not benefit from allogeneic stem-cell transplantation | Leukemia | 2020 | 233 | 0 | |||
| Atelier d'harmonisations 2019 : indications et organisation d'une microtransplantation de cellules souches hématopoïétiquesIndications and management of hematologic microtransplantation: Recommendations of the French Society of Bone Marrow transplantation and cellular Therapy (SFGM-TC) | Bulletin du cancer | 2020 | 242 | 0 | |||
| Phosphonoformate Crystalluria, A Warning Signal of Foscarnet-Induced Kidney Injury | Kidney international reports | 2020 | 344 | 138 | |||
| Progressive multifocal leukoencephalopathy responsive to withdrawal of imatinib in a patient with FIP1L1-PDGFRA positive myeloid neoplasm | Leukemia and Lymphoma | 2020 | 204 | 0 | |||
| Intracellular Pathogen in the Cerebrospinal Fluid of an Allogeneic Hematopoietic Cell Transplant Recipient With Graft-Versus-Host Disease and Brain Lesions | Clinical infectious diseases | 2020 | 275 | 0 | |||
| Burden and Timeline of Infectious Diseases in the First Year After Solid Organ Transplantation in the Swiss Transplant Cohort Study | Clinical Infectious Diseases | 2020 | 346 | 244 | |||
| Evaluation of Disease Risk Comorbidity Index after Allogeneic Stem Cell Transplantation in a Cohort with Patients Undergoing Transplantation with In Vitro Partially T Cell Depleted Grafts | Biology of Blood and Marrow Transplantation | 2020 | 340 | 298 | |||
| Optimal treatment duration of pseudomonas aeruginosa infections in allogeneic hematopoietic cell transplant recipients | Open Forum Infectious Diseases | 2020 | 465 | 153 | |||
| Facteurs de croissance granulocytaire dans le traitement curatif desneutropénies fébriles | Revue médicale suisse | 2020 | 300 | 0 | |||
| Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial | Blood Advances | 2020 | 289 | 192 | |||
| Outcome of allogeneic haematopoietic stem cell transplantation in myeloproliferative neoplasm, unclassifiable: a retrospective study by the Chronic Malignancies Working Party of the EBMT | British Journal of Haematology | 2020 | 216 | 0 | |||
| Comparing Dried Blood Spots and Plasma Concentrations for Busulfan Therapeutic Drug Monitoring in Children | Therapeutic Drug Monitoring | 2020 | 454 | 224 | |||
| Nonmyeloablative Alternative Donor Transplantation for Hodgkin and Non-Hodgkin Lymphoma: From the LWP-EBMT, Eurocord, and CIBMTR | Journal of Clinical Oncology | 2020 | 165 | 0 | |||
| Influence of donor type, stem cell source and conditioning on outcomes after haploidentical transplant for lymphoma - a LWP-EBMT study | British Journal of Haematology | 2020 | 328 | 0 | |||
| Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for T Cell Acute Lymphoblastic Leukemia: A Report from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party | Biology of Blood and Marrow Transplantation | 2020 | 294 | 0 | |||
| Microbiologically documented infections after adult allogeneic hematopoietic cell transplantation: A 5-year analysis within the Swiss Transplant Cohort study | Transplant Infectious Disease | 2020 | 407 | 2 | |||
| Myeloablative and Reduced-Intensity Conditioned Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis: A Retrospective Study by the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation | Biology of Blood and Marrow Transplantation | 2019 | 595 | 393 | |||
| Epigenetic Silencing Affects l-Asparaginase Sensitivity and Predicts Outcome in T-ALL | Clinical Cancer Research | 2019 | 300 | 0 | |||
| Vitamin d status and risk of infections after liver transplantation in the swiss transplant cohort study | Transplant International | 2019 | 553 | 0 | |||
| Antilymphocyte globulin for matched sibling donor transplantation in patients with myelofibrosis | Haematologica | 2019 | 386 | 183 | |||
| Allogeneic Stem Cell Transplantation in Therapy-Related Myelodysplasia after Autologous Transplantation for Lymphoma: A Retrospective Study of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy | Biology of Blood and Marrow Transplantation | 2019 | 303 | 0 | |||
| Dynamics of Expression of Programmed Cell Death Protein-1 (PD-1) on T Cells After Allogeneic Hematopoietic Stem Cell Transplantation | Frontiers in Immunology | 2019 | 360 | 180 | |||
| State-of-the-art review: allogeneic stem cell transplantation for myelofibrosis in 2019 | Haematologica | 2019 | 365 | 368 | |||
| γ-Catenin-Dependent Signals Maintain BCR-ABL1+ B Cell Acute Lymphoblastic Leukemia | Cancer Cell | 2019 | 298 | 0 | |||
| Clinical and biological features of PTPN2-deleted adult and pediatric T-cell acute lymphoblastic leukemia | Blood Advances | 2019 | 269 | 246 | |||
| High-resolution HLA phased haplotype frequencies to predict the success of unrelated donor searches and clinical outcome following hematopoietic stem cell transplantation | Bone Marrow Transplantation | 2019 | 459 | 149 | |||
| DNMT3A mutation is associated with increased age and adverse outcome in adult T-cell acute lymphoblastic leukemia | Haematologica | 2019 | 232 | 202 | |||
| A rare case of immune thrombocytopenia secondary to breast cancer | Clinical Case Reports | 2019 | 337 | 154 | |||
| PAX5 P80R mutation identifies a novel subtype of B-cell precursor acute lymphoblastic leukemia with favorable outcome | Blood | 2019 | 302 | 1 | |||
| Allogeneic stem cell transplantation for blast crisis chronic myeloid leukemia in the era of tyrosine kinase inhibitors: a retrospective study by the EBMT chronic malignancies working party | Biology of Blood and Marrow Transplantation | 2019 | 285 | 0 | |||
| Comparison of Dynamic International Prognostic Scoring System and MYelofibrosis SECondary to PV and ET Prognostic Model for Prediction of Outcome in Polycythemia Vera and Essential Thrombocythemia Myelofibrosis after Allogeneic Stem Cell Transplantation | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation | 2019 | 290 | 0 | |||
| Impact of primary disease on outcome after allogeneic stem cell transplantation for transformed secondary acute leukaemia | British Journal of Haematology | 2019 | 314 | 0 | |||
| Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis | Haematologica | 2019 | 320 | 285 | |||
| Partial T-cell depletion improves the composite endpoint graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic stem cell transplantation | Leukemia and Lymphoma | 2018 | 546 | 2 | |||
| Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort Study | Transplant Infectious Disease | 2018 | 593 | 0 | |||
| Family mismatched allogeneic stem cell transplantation for Myelofibrosis: Report from the Chronic Malignancies Working Party of EBMT | Biology of Blood and Marrow Transplantation | 2018 | 413 | 0 | |||
| Successful Ovarian Stimulation for Fertility Preservation in a Patient with Chronic Myeloid Leukemia: Switch from Nilotinib to Interferon-α | The Oncologist | 2018 | 445 | 0 | |||
| Haematopoietic cell transplantation in Switzerland, changes and results over 20 years: a report from the Swiss Blood Stem Cell Transplantation Working Group for Blood and Marrow Transplantation registry 1997-2016 | Swiss Medical Weekly | 2018 | 505 | 320 | |||
| Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT | British Journal of Haematology | 2018 | 426 | 0 | |||
| Central nervous system graft-versus-host disease (CNS-GvHD) after allogeneic haematopoietic stem cell transplantation | BMJ Case Reports | 2018 | 436 | 1 | |||
| Impact of T-cell depletion on outcome of patients undergoing allogeneic hematopoietic cell transplantation for myelodysplastic syndrome | Bone Marrow Transplantation | 2018 | 460 | 0 | |||
| Intensified Therapy of Acute Lymphoblastic Leukemia in Adults: Report of the Randomized GRAALL-2005 Clinical Trial | Journal of Clinical Oncology | 2018 | 455 | 1 | |||
| Better outcome with haploidentical over HLA-matched related donors in patients with Hodgkin's lymphoma undergoing allogeneic haematopoietic cell transplantation-a study by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy | Bone Marrow Transplantation | 2018 | 457 | 0 | |||
| Incidence and outcome of invasive fungal diseases after allogeneic hematopoietic stem cell transplantation: A Swiss transplant cohort study | Transplant Infectious Disease | 2018 | 473 | 0 | |||
| Clinical and morphological practices in the diagnosis of transplant-associated microangiopathy: a study on behalf of Transplant Complications Working Party of the EBMT | Bone Marrow Transplantation | 2018 | 365 | 0 | |||
| Improvement of relative survival in elderly patients with acute myeloid leukaemia emerging from population-based cancer registries in Switzerland between 2001 and 2013 | Cancer Epidemiology | 2018 | 413 | 0 | |||
| Anemie hemolytique dans le contexte de cancer | Revue médicale suisse | 2018 | 520 | 923 | |||
| Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia Relapse | JAMA Oncology | 2018 | 455 | 0 | |||
| Therapeutic Drug Monitoring of Busulfan for the Management of Pediatric Patients: Cross-Validation of Methods and Long-Term Performance | Therapeutic Drug Monitoring | 2018 | 866 | 837 | |||
| Human pegivirus persistence in the human blood virome after allogeneic haematopoietic stem cell transplantation | Clinical Microbiology and Infection | 2018 | 1,399 | 631 | |||
| Allogeneic stem cell transplantation in patients with atypical chronic myeloid leukaemia: a retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation | British Journal of Haematology | 2017 | 332 | 0 | |||
| Torque Teno Virus Load and Acute Rejection after Orthotopic Liver Transplantation | Transplantation | 2017 | 848 | 0 | |||
| Prérequis nécessaires pour la mise en place de protocoles de recherche clinique évaluant des thérapies cellulaires et géniques par lymphocytes T dotés de récepteur chimérique à l'antigène (CAR T-cells) | Bulletin du cancer | 2017 | 515 | 0 | |||
| Baseline Characteristics Predicting Very Good Outcome of Allogeneic Hematopoietic Cell Transplantation in Young Patients With High Cytogenetic Risk Chronic Lymphocytic Leukemia | Clinical Lymphoma Myeloma and Leukemia | 2017 | 329 | 0 | |||
| Adaptation des doses de médicament des conditionnements de greffe de cellules souches hématopoïétiques dans des populations avec comorbidité | Bulletin du cancer | 2017 | 369 | 0 | |||
| Cerebral Rhizomucor Infection Treated by Posaconazole Delayed-Release Tablets in an Allogeneic Stem Cell Transplant Recipient | International journal of infectious diseases | 2017 | 629 | 213 | |||
| FLT3-ITD mutations do not impact the outcome of patients allografted with partial T-cell depleted grafts for AML with normal cytogenetics in first complete remission | Hematological oncology | 2017 | 541 | 3 | |||
| GSTA1 diplotypes affect busulfan clearance and toxicity in children undergoing allogeneic hematopoietic stem cell transplantation: a multicenter study | Oncotarget | 2017 | 560 | 322 | |||
| The Association of Combined GSTM1 and CYP2C9 Genotype Status with the Occurrence of Hemorrhagic Cystitis in Pediatric Patients Receiving Myeloablative Conditioning Regimen Prior to Allogeneic Hematopoietic Stem Cell Transplantation | Frontiers in Pharmacology | 2017 | 622 | 279 | |||
| Lack of association between relationship status and clinical outcome in allogeneic stem cell transplantation-the Swiss Transplant Cohort Study | Bone Marrow Transplantation | 2017 | 312 | 0 | |||
| Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AML | Blood | 2017 | 517 | 0 | |||
| Centre characteristics and procedure-related factors have an impact on outcomes of allogeneic transplantation for patients with CLL: a retrospective analysis from the European Society for Blood and Marrow Transplantation (EBMT) | British journal of haematology | 2017 | 189 | 0 | |||
| Impact of cytogenetic abnormalities in adults with Ph-negative B-cell precursor acute lymphoblastic leukemia | Blood | 2017 | 563 | 0 | |||
| TAFRO Syndrome in Caucasians: A Case Report and Review of the Literature | Frontiers in Medicine | 2017 | 521 | 284 | |||
| Syndrome hémophagocytaire réactionnel | Revue médicale suisse | 2017 | 549 | 430 | |||
| Nutritional support practices in hematopoietic stem cell transplantation centers: A nationwide comparison | Nutrition | 2017 | 541 | 1 | |||
| Greffe de cellules-souches hématopoïétiques haplo-identiques : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC) | Bulletin du cancer | 2016 | 541 | 0 | |||
| Rituximab in B-Lineage Adult Acute Lymphoblastic Leukemia | New England Journal of Medicine | 2016 | 598 | 360 | |||
| Complete remission of disseminated granulomatous dermatitis related to chronic eosinophilic leukemia following allogeneic stem cell transplantation | Leukemia & lymphoma | 2016 | 1,217 | 1 | |||
| Outcome of hematopoietic stem cell transplantation is similar for patients with a partial in vitro T-cell-depleted graft compared with a non-T-cell-depleted graft when stratified by the refined disease risk index | Bone marrow transplantation | 2016 | 652 | 2 | |||
| Excellent outcome with a high proportion of mixed chimerism in patients with severe aplastic anemia treated with partially T-cell-depleted peripheral hematopoietic stem cell transplants | Bone marrow transplantation | 2016 | 681 | 4 | |||
| Comparison of Intensive Chemotherapy and Hypomethylating Agents before Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndromes | Biology of Blood and Marrow Transplantation | 2016 | 313 | 245 | |||
| Immunological Basis of Bone Marrow Failure after Allogeneic Hematopoietic Stem Cell Transplantation | Frontiers in Immunology | 2016 | 519 | 317 | |||
| Torque teno virus in patients undergoing allogeneic hematopoietic stem cell transplantation for hematological malignancies | Bone marrow transplantation | 2016 | 511 | 2 | |||
| Post-artesunate delayed haemolysis ‒ report of four cases and review of the literature | Schweizerische medizinische Wochenschrift | 2015 | 598 | 317 | |||
| Reply to Cunha et al | Clinical infectious diseases | 2015 | 281 | 0 | |||
| Achievement of complete remission predicts outcome of allogeneic haematopoietic stem cell transplantation in patients with chronic myelomonocytic leukaemia. A study of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation | British journal of haematology | 2015 | 178 | 0 | |||
| Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia | Blood | 2015 | 315 | 376 | |||
| Complete and sustained remission of spondyloarthritis after allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome | Joint bone spine | 2015 | 615 | 2 | |||
| Very Long Term Stability of Mixed Chimerism after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematologic Malignancies | Bone marrow research | 2015 | 588 | 216 | |||
| In-Hospital Transfer Is a Risk Factor for Invasive Filamentous Fungal Infection among Hospitalized Patients with Hematological Malignancies: A Matched Case-Control Study | Infection control and hospital epidemiology | 2015 | 622 | 1 | |||
| Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia | Blood | 2015 | 663 | 0 | |||
| NK Cell Functional Impairment after Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Reduced Levels of T-bet and Eomesodermin | The Journal of immunology | 2015 | 561 | 3 | |||
| Comparing Two Types of Rabbit ATG prior to Reduced Intensity Conditioning Allogeneic Hematopoietic SCT for Hematologic Malignancies | Bone marrow research | 2015 | 719 | 368 | |||
| E119D Neuraminidase Mutation Conferring Pan-Resistance to Neuraminidase Inhibitors in an A(H1N1)pdm09 Isolate From a Stem-Cell Transplant Recipient | The Journal of infectious diseases | 2015 | 766 | 0 | |||
| Clinical usefulness of therapeutic concentration monitoring for imatinib dosage individualization: results from a randomized controlled trial | Cancer chemotherapy and pharmacology | 2014 | 588 | 0 | |||
| Unrelated cord blood transplantation for patients with primary or secondary myelofibrosis | Biology of blood and marrow transplantation | 2014 | 607 | 1 | |||
| Monitoring white blood cell count in adult patients with schizophrenia who are taking clozapine: a cost-effectiveness analysis | The Lancet. Psychiatry | 2014 | 560 | 0 | |||
| The impact of T-cell depletion techniques on the outcome after haploidentical hematopoietic SCT | Bone marrow transplantation | 2014 | 792 | 448 | |||
| Early administration of donor lymphocyte infusions upon molecular relapse after allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia: a study by the Chronic Malignancies Working Party of the EBMT | Haematologica | 2014 | 594 | 633 | |||
| Validation of the disease risk index for outcome of patients undergoing allogeneic hematopoietic stem cell transplantation after T cell depletion | Biology of blood and marrow transplantation | 2014 | 624 | 1 | |||
| A rare case of primary cutaneous follicle centre lymphoma presenting as a giant tumour of the scalp and combined with JAK2V617F positive essential thrombocythaemia | Biomarker research | 2014 | 688 | 285 | |||
| Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia | Blood | 2014 | 572 | 0 | |||
| Azacytidine for acute myeloid leukemia in elderly or frail patients: a phase II trial (SAKK 30/07) | Leukemia & lymphoma | 2014 | 737 | 1,342 | |||
| Haematopoietic stem cell transplantation: activity in Switzerland compared with surrounding European countries | Schweizerische medizinische Wochenschrift | 2013 | 685 | 1 | |||
| Reversible ventricular arrythmia induced by dasatinib | Clinical case reports | 2013 | 659 | 251 | |||
| Radioimmunotherapy combined with maintenance anti-CD20 antibody may trigger long-term protective T cell immunity in follicular lymphoma patients | Clinical & developmental immunology | 2013 | 650 | 607 | |||
| Autologous bone marrow mononuclear cell transplantation in patients with decompensated alcoholic liver disease: a randomized controlled trial | PloS one | 2013 | 776 | 287 | |||
| A phase I dose-escalation study of MSC1992371A, an oral inhibitor of aurora and other kinases, in advanced hematologic malignancies | Leukemia research | 2013 | 733 | 737 | |||
| Toward a NOTCH1/FBXW7/RAS/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study | Journal of clinical oncology | 2013 | 1,158 | 1,150 | |||
| The clinical relevance of pre-formed anti-HLA and anti-MICA antibodies after cord blood transplantation in children | PloS one | 2013 | 729 | 426 | |||
| Long-term follow-up of the imatinib GRAAPH-2003 study in newly diagnosed patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: a GRAALL study | Biology of blood and marrow transplantation | 2013 | 704 | 514 | |||
| High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON/SAKK AML 42A study | Journal of clinical oncology | 2013 | 1,386 | 1,455 | |||
| Long-term deregulated human hematopoiesis in goats transplanted in utero with BCR-ABL-transduced lin(-)CD34(+) cord blood cells | Cell Research | 2013 | 590 | 398 | |||
| Initial cord blood unit volume affects mononuclear cell and CD34+ cell-processing efficiency in a non-linear fashion | Cytotherapy | 2012 | 737 | 0 | |||
| Third-party mesenchymal stromal cell infusion is associated with a decrease in thrombotic microangiopathy symptoms observed post-hematopoietic stem cell transplantation | Pediatric transplantation | 2012 | 732 | 0 | |||
| Clinical features and outcome of 2009-influenza A (H1N1) after allogeneic hematopoietic SCT | Bone marrow transplantation | 2012 | 798 | 0 | |||
| Longer intervals between hematopoietic stem cell transplantation and subsequent 90Y-ibritumomab radioimmunotherapy may correlate with better tolerance | Clinical nuclear medicine | 2012 | 531 | 0 | |||
| Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients | Haematologica | 2011 | 1,056 | 668 | |||
| Do NK cells contribute to the pathophysiology of transplant-associated thrombotic microangiopathy? | American journal of transplantation | 2011 | 733 | 0 | |||
| Outcome and risk factors for late-onset complications 24 months beyond allogeneic hematopoietic stem cell transplantation | European journal of haematology | 2011 | 684 | 0 | |||
| Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study | Arthritis and rheumatism | 2011 | 884 | 8 | |||
| Cotrimoxazole myelotoxicity in hematopoietic SCT recipients: time for reappraisal | Bone marrow transplantation | 2011 | 605 | 0 | |||
| A Case of Drug-Induced Hepatitis due to Lenalidomide | Case reports in gastroenterology | 2011 | 615 | 0 | |||
| Impact of HLA-DPB1 haplotypes on outcome of 10/10 matched unrelated hematopoietic stem cell donor transplants depends on MHC-linked microsatellite polymorphisms | Biology of blood and marrow transplantation | 2011 | 655 | 0 | |||
| Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1/FBXW7 mutations, but not of low ERG/BAALC expression: a GRAALL study | Blood | 2011 | 726 | 0 | |||
| Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the Chronic Leukemia Working Party of the EBMT | Bone marrow transplantation | 2010 | 561 | 0 | |||
| Clonal heterogeneity and chromosomal instability at disease presentation in high hyperdiploid acute lymphoblastic leukemia | Cancer genetics and cytogenetics | 2010 | 650 | 0 | |||
| Disseminated Rhizopus microsporus infection cured by salvage allogeneic hematopoietic stem cell transplantation, antifungal combination therapy, and surgical resection | Transplant infectious disease | 2010 | 715 | 0 | |||
| Adverse prognostic significance of CD20 expression in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia | Haematologica | 2010 | 647 | 0 | |||
| CD56bright NK cells after hematopoietic stem cell transplantation are activated mature NK cells that expand in patients with low numbers of T cells | European Journal of Immunology | 2010 | 684 | 0 | |||
| Invasive microsporidiosis in allogeneic haematopoietic SCT recipients | Bone marrow transplantation | 2010 | 575 | 0 | |||
| Hodgkin's lymphoma relapsing after autologous transplantation: allogeneic hematopoietic stem cell transplantation using a strategy of reduced intensity conditioning, and T-cell depletion with T-cell add-back | European journal of haematology | 2009 | 588 | 0 | |||
| Cord blood banks collect units with different HLA alleles and haplotypes to volunteer donor banks: a comparative report from Swiss Blood stem cells | Bone marrow transplantation | 2009 | 687 | 0 | |||
| PAX5 mutations occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and PAX5 haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL study | Leukemia | 2009 | 814 | 0 | |||
| Atypical presentation of acute myeloid leukemia: cardiac myeloid sarcoma | International journal of hematology | 2009 | 643 | 0 | |||
| Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia : the GRAALL-2003 study | Journal of clinical oncology | 2009 | 108 | 0 | |||
| Quality of life and social integration after allogeneic hematopoietic SCT | Bone marrow transplantation | 2008 | 629 | 0 | |||
| Les leucémies aiguës | Revue médicale suisse | 2008 | 564 | 2 | |||
| Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: a randomized trial | Hepatology | 2008 | 692 | 0 | |||
| Reconstitution of the immune system after hematopoietic stem cell transplantation in humans | Seminars in immunopathology | 2008 | 579 | 890 | |||
| Steroid-responsive cauda equina syndrome associated with GVHD after allogeneic hematopoietic stem cell transplantation | Bone marrow transplantation | 2008 | 598 | 0 | |||
| Breakthrough invasive pulmonary aspergillosis despite empirical voriconazole therapy for febrile neutropenia: case report and review of the literature | Scandinavian journal of infectious diseases | 2007 | 703 | 0 | |||
| The probability of identifying a 10/10 HLA allele-matched unrelated donor is highly predictable | Bone marrow transplantation | 2007 | 543 | 0 | |||
| Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study | Blood | 2007 | 609 | 0 | |||
| Invasive zygomycosis in transplant recipients | Clinical transplantation | 2007 | 639 | 0 | |||
| Pretransplantation CMV-specific T cells protect recipients of T-cell-depleted grafts against CMV-related complications | Blood | 2006 | 641 | 0 | |||
| Longitudinal follow-up of body composition in hematopoietic stem cell transplant patients | Bone marrow transplantation | 2005 | 185 | 0 | |||
| Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation | Biology of blood and marrow transplantation | 2004 | 620 | 0 |
